Thus, one of the most effective therapeutic approaches to treating hormone-dependent breast cancer is to deprive cancer cells of estrogens by using drugs acting on the estrogen receptor (ER) or inhibiting the aromatase enzyme [3,4,5,6]. This evidence concerns the gene ESR1 and cancer.